• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제29권6호
• /
• pp.485-493
• /
• 2007

Introduction: Although several types of calcium-phosphate coumpound have been frequently applied to osseous defects at maxillofacial area for many years, there is a controversy about its efficiency on bone conductivity comprared to xenograft bone substitute. Alloplastic carbonapatite has been introduced to improve disadvantages of hydroxyapatite and to mimic natural bone containing carbon elements. However, a preclinical study about its efficiency of osteoconductivity has not been reported. This study was performed to evaluate the early osteoconductive potential of synthetic carbonapatite with multiple pores relative to anorganic bovine xenograft. Materials and methods: Total 5 beagle dogs were used for maxillary augmentation model. The control (anorganic bovine xenograft) and experimental groups (synthetic carbonapatite) were randomly distributed in the mouth split design. After bone graft, all animals were sacrificed 4 weeks after surgery. Histological specimens with Masson Trichrome staining were made and histomorphometrically analysed with image analyser. The statistical analysis was performed using paired t-test. Results: In both groups, all animals had no complications. The experimental group showed relatively much new bone formation around and along the bone substitutes, whereas it was clearly reduced in the control group. The ratios of new bone area to total area, to material area and to the residual area excluding materials were higher in the experimental group ($0.13{\pm}0.03,\;0.40{\pm}0.13,\;0.20{\pm}0.06$ respectively) than in the control group ($0.01{\pm}0.01,\;0.03{\pm}0.02,\;0.03{\pm}0.03$, respectively). And the differences between both groups were statistically significant (p<0.001, <0.01, <0.01, respectively), while the ratio of material area to total area in two groups was not significant. Conclusion: Carbonapatite showed a high osteoconductivity in the early stage of bone healing compared to bovine derived anorganic bone substitute. This study suggests that this bone materials can be applied as a reliable bone substitute in the clinical treatment.

• Radiation Oncology Journal
• /
• 제25권4호
• /
• pp.233-241
• /
• 2007

목적: EGFR, HER2 과발현 인간 유방암 세포를 이용한 종양이식 마우스에서 EGFR/HER2 복합 Tyrosine Kinase 억제제인 GW572016이 방사선반응성에 미치는 영향을 알아보고 종양조직의 EGFR/HER2수용체 억제효과 및 EGFR down stream signal pathway 단백인 ERK 1/2, PI3k/Akt 억제효과를 알아보고자 하였다. 대상 및 방법: SUM 102와 SUM 149 EGFR 과발현 세포와 SUM 185, SUM 225 HER2 과발현 세포를 우측 옆구리 피하에 접종하여 종양이식마우스를 만들었다. 이식마우스는 2군으로 나누어 한 군은 GW572016에 의한 EGFR/HER2 수용체 억제와 down stream signal 단백의 활성 변화를 Immunoprecipitation과 Western blot의 방법을 사용하여 관찰하였고 다른 한군은 GW572016에 의한 방사선감수성 변화를 알아보기 위해 1) 대조군, 2) GW572016 단독군, 3) 방사선단독군, 4) GW572016+방사선병용투여군으로 나누어 종양성장을 비교 관찰하였다. GW572016에 의해서 SUM 149, SUM 185이식종양에서 EGFR및 HER2 수용체의 활성이 억제되었으며 특히 SUM 185, HER2 과발현 이식종양에서는 ERK 1/2 down stream 단백의 활성도 억제되었다 SUM 225 HEH2 과발현 이식종양에서는 이전의 in vitro실험에서와 달리 GW572016에 의해 HER2수용체의 활성변화가 없었으나 ERK 1/2, Akt의 활성은 모두 억제되었다. GW572016에 의해 SUM 149과 SUM 185에서 종양성장억제효과가 관찰되었고 특히 SUM 149에서는 GW572016과 방사선치료병용군에서 종양성장억제효과가 좀더 뚜렷하여 방사선감수성을 증가시키는 것으로 생각되었다. 결 론: GW572016은 EGFR 혹은 HER2 과발현 유방암세포에서 EGFR/HER2 수용체 억제와 down stream signal 단백의 활성을 억제시켰으며 SUM 149에서는 방사선감수성을 증가시키는 것으로 생각된다. 향후 EGFR을 표적으로 하는 억제제치료에서 EGFR 수용체억제뿐 아니라 down stream 단백의 활성억제 여부가 방사선 감수성 및 저항성의 극복과 관련이 있으리라는 근거를 설명할 수 있으며 향후 좀더 깊이 있는 연구가 필요하다.

• 대한치주과학회:학술대회논문집
• /
• 대한치주과학회 2004년도 춘계학술대회
• /
• pp.16-16
• /
• 2004

• 대한치과의사협회지
• /
• 제51권12호
• /
• pp.643-649
• /
• 2013

The aim of this study was to achieve the healing of peri-implantitis defects and the hard tissue regeneration using the augmentation of a xenograft on defect site. Two patients were treated with the surgical approach. With a full muco-periosteal flap elevation, the implant surfaces were exposed and taken the debridement of granulation tissue around the abutment. Each surface of the abutments was prepared with the air-abrasive device (PerioFlow$^{(R)}$) for decontamination. Bovine-derived bone mineral (Bio-Oss collagen$^{(R)}$) was then used to fill the defects, and no membrane was placed on the grafting site. Radiographs and clinical photo was taken to compare from baseline status. Within the limits of the present case, this case shows the significance of the surgical treatment of peri-implantitis. And this also verifies the stability of bovine-derived bone mineral and effectiveness of Air-abrasive device (PerioFlow$^{(R)}$).

• Archives of Plastic Surgery
• /
• 제48권2호
• /
• pp.185-188
• /
• 2021

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome can be treated through numerous surgical and nonsurgical methods. We present a surgical technique in which a neovagina was reconstructed and shaped by a vaginal expander with acellular porcine dermal matrix (XCM Biologic Tissue Matrix) and mucosal interposition using microfragments harvested from the hymen. In our case, we found this procedure to be safe and effective, resulting in satisfactory sexual function and good cosmetic results, without donor site morbidity. To our best knowledge, this tissue-engineered biomaterial has never been used for vaginal reconstruction before.

• Journal of Veterinary Science
• /
• 제23권6호
• /
• pp.89.1-89.7
• /
• 2022

It is challenging to diagnose metastatic tumors whose cellular morphology is different from the primary. We characterized canine primary pulmonary adenocarcinoma (PAC) and its xenografted tumors by histological and immunohistochemical analyses for critical diagnostic and cancer stem cell (CSC) markers. To generate a tumor xenograft model, we subsequently transplanted the tissue pieces from the PAC into athymic nude mice. Immunohistochemical examination was performed for diagnostic (TTF-1, Napsin A, and SP-A) and CSC markers (CD44 and CD133). The use of CSC markers together with diagnostic markers can improve the detection and diagnosis of canine primary and metastatic adenocarcinomas.

• 대한치과의사협회지
• /
• 제38권3호통권370호
• /
• pp.225-231
• /
• 2000

• 대한치과보철학회:학술대회논문집
• /
• 대한치과보철학회 2002년도 추계학술대회
• /
• pp.117-118
• /
• 2002

• 한국수의병리학회:학술대회논문집
• /
• 한국수의병리학회 2005년도 Proceedings of The 2nd Asian Society of Veterinary Pathology Symposium(Vol.2) and 2005 Annual Meeting of The Korean Society of Veterinary Pathology(Vol.9)
• /
• pp.75-76
• /
• 2005

• 대한한방내과학회지
• /
• 제33권4호
• /
• pp.387-404
• /
• 2012

Objectives : This study was to observe anticancer and related immunomodulatory effects of Kwibi-tang extracts (KBTe) on non-small cell lung carcinoma (squamous epithelial carcinoma), NCI-H520, xenograft Balb/c nu-nu nude mice. Methods : Three different dosages of KBTe, 50, 100 and 200 mg/kg were orally administered once a day for 42 days from 11 days after tumor cell inoculation. Six groups, each of 8 mice per group were used in the present study. Changes in body weight, tumor volume and weight, lymphatic organs (spleen and popliteal lymph node), serum interferon (IFN)-${\gamma}$ levels, splenocytes NK cell activity and peritoneal macrophage activities, splenic tumor necrosis factor (TNF)-${\alpha}$, interleukin (IL)-$1{\beta}$ and IL-10 contents were observed with tumor mass and lymphatic organ histopathology to detect anticancer and immunomodulatory effects. The results were compared with a potent cytotoxic anticancer agent, 5-FU (5-Fluorouracil) 30 mg/kg, intraperitoneal treatment (3-day intervals for 42 days, the optimal effective treatment regimes already confirmed). Results & Conclusions : This study suggest that over 50 mg/kg of KBTe showed favorable anticancer effects on the NCI-H520 cell xenograft with immunomodulatory effects. Although relatively lower anticancer effects were observed in KBTe 200 mg/kg treated mice as compared with 5-FU 30 mg/kg treated mice, no meaningful favorable immunomodulatory effects were observed after 5-FU treatment in the present study.